Beloqui O - Search Results

1

Prognosis of hepatocellular carcinoma in relation to treatment: a multivariate analysis of 178 patients from a single European institution.

Sangro B, Herráiz M, Martínez-González MA, Bilbao I, Herrero I, Beloqui O, Betés M, de-la-Peña A, Cienfuegos JA, Quiroga J, Prieto J. Sangro B, et al. Among authors: beloqui o. Surgery. 1998 Sep;124(3):575-83. Surgery. 1998. PMID: 9736912

2

Efficacy and toxicity of intra-arterial cisplatin and etoposide for advanced hepatocellular carcinoma.

Sangro B, Rios R, Bilbao I, Beloqui O, Herrero JI, Quiroga J, Prieto J. Sangro B, et al. Among authors: beloqui o. Oncology. 2002;62(4):293-8. doi: 10.1159/000065059. Oncology. 2002. PMID: 12138235

3

Splenic embolization prior to myelosuppressive treatment in hepatocarcinoma and active chronic hepatitis.

Bilbao JI, Sangro B, Longo JM, Zozaya JM, Fernández-Virgós A, Aquerreta JD, Beloqui O, Prieto J. Bilbao JI, et al. Among authors: beloqui o. Eur J Radiol. 1992 Oct;15(3):211-4. doi: 10.1016/0720-048x(92)90109-m. Eur J Radiol. 1992. PMID: 1337037

4

Hepatitis B and C viral infections in patients with hepatocellular carcinoma.

Ruiz J, Sangro B, Cuende JI, Beloqui O, Riezu-Boj JI, Herrero JI, Prieto J. Ruiz J, et al. Among authors: beloqui o. Hepatology. 1992 Sep;16(3):637-41. doi: 10.1002/hep.1840160305. Hepatology. 1992. PMID: 1380480

5

Partial splenic embolization for the treatment of hypersplenism in cirrhosis.

Sangro B, Bilbao I, Herrero I, Corella C, Longo J, Beloqui O, Ruiz J, Zozaya JM, Quiroga J, Prieto J. Sangro B, et al. Among authors: beloqui o. Hepatology. 1993 Aug;18(2):309-14. Hepatology. 1993. PMID: 8340060

6

Hyperhomocysteinemia in liver transplant recipients: prevalence and multivariate analysis of predisposing factors.

Herrero JI, Quiroga J, Sangro B, Beloqui O, Pardo F, Cienfuegos JA, Prieto J. Herrero JI, et al. Among authors: beloqui o. Liver Transpl. 2000 Sep;6(5):614-8. doi: 10.1053/jlts.2000.7571. Liver Transpl. 2000. PMID: 10980061 Free article.

7

Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome.

Prieto J, Yuste JR, Beloqui O, Civeira MP, Riezu JI, Aguirre B, Sangro B. Prieto J, et al. Among authors: beloqui o. Hepatology. 1996 Feb;23(2):199-204. doi: 10.1002/hep.510230201. Hepatology. 1996. PMID: 8591841

8

Superoxide dismutase in patients with chronic hepatitis C virus infection.

Larrea E, Beloqui O, Muñoz-Navas MA, Civeira MP, Prieto J. Larrea E, et al. Among authors: beloqui o. Free Radic Biol Med. 1998 May;24(7-8):1235-41. doi: 10.1016/s0891-5849(97)00437-1. Free Radic Biol Med. 1998. PMID: 9626579 Free article.

9

Antioxidant status and glutathione metabolism in peripheral blood mononuclear cells from patients with chronic hepatitis C.

Boya P, de la Peña A, Beloqui O, Larrea E, Conchillo M, Castelruiz Y, Civeira MP, Prieto J. Boya P, et al. Among authors: beloqui o. J Hepatol. 1999 Nov;31(5):808-14. doi: 10.1016/s0168-8278(99)80281-5. J Hepatol. 1999. PMID: 10580577 Free article.

10

[Extrahepatic manifestations of hepatitis C virus].

Yuste JR, Beloqui O, Garcia N, Prieto J. Yuste JR, et al. Among authors: beloqui o. An Med Interna. 1995 Dec;12(12):609-16. An Med Interna. 1995. PMID: 8679807 Review. Spanish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters